Genetic Engineering & Biotechnology News
·
Lexent Bio is currently developing a test, Confera, that will measure a cancer's response to treatment and hope the test will be made available next year. Lexent recently announced a nonexclusive partnership with Illumina to develop the kits.
genengnews.com/news/measuri...
#LexentBio #Illumina #Cancer #LiquidBiopsies